{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:43:14Z","timestamp":1791168194224,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurologic.theclinics.com","mdconsult.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ncl.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T05:23:30Z","timestamp":1405488210000},"page":"777-799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Metabolic and Mitochondrial Myopathies"],"prefix":"10.1016","volume":"32","author":[{"given":"Lydia J.","family":"Sharp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ncl.2014.05.001_bib1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","article-title":"Spontaneous \u201csecond wind\u201d and glucose-induced second \u201csecond wind\u201d in McArdle disease: oxidative mechanisms","volume":"59","author":"Haller","year":"2002","journal-title":"Arch Neurol"},{"issue":"Suppl 3","key":"10.1016\/j.ncl.2014.05.001_bib2","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.nmd.2012.10.011","article-title":"Mechanisms of exertional fatigue in muscle glycogenoses","volume":"22","author":"Vissing","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"Pt 6","key":"10.1016\/j.ncl.2014.05.001_bib3","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/brain\/awp065","article-title":"Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease","volume":"132","author":"Vissing","year":"2009","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.ncl.2014.05.001_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ncpneuro0913","article-title":"McArdle disease: what do neurologists need to know?","volume":"4","author":"Lucia","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jnnp-2011-301593","article-title":"Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry","volume":"83","author":"Lucia","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.ncl.2014.05.001_bib6","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.2009.195040","article-title":"McArdle disease: a clinical review","volume":"81","author":"Quinlivan","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.ncl.2014.05.001_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.nmd.2011.07.002","article-title":"Molecular and clinical study of McArdle's disease in a cohort of 123 European patients. Identification of 20 novel mutations","volume":"21","author":"Vieitez","year":"2011","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.ncl.2014.05.001_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.1225","article-title":"Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study","volume":"50","author":"Martin","year":"2001","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2014.05.001_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ana.10263","article-title":"A\u00a0nonischemic forearm exercise test for McArdle disease","volume":"52","author":"Kazemi-Esfarjani","year":"2002","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2014.05.001_bib10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ana.20881","article-title":"Aerobic conditioning: an effective therapy in McArdle's disease","volume":"59","author":"Haller","year":"2006","journal-title":"Ann Neurol"},{"issue":"26","key":"10.1016\/j.ncl.2014.05.001_bib11","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa031836","article-title":"The effect of oral sucrose on exercise tolerance in patients with McArdle's disease","volume":"349","author":"Vissing","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ncl.2014.05.001_bib12","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1073\/pnas.85.9.2929","article-title":"cDNA cloning and complete primary structure of skeletal muscle phosphorylase kinase (alpha subunit)","volume":"85","author":"Zander","year":"1988","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.ncl.2014.05.001_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1212\/WNL.36.4.560","article-title":"Adult muscle phosphorylase \u201cb\u201d kinase deficiency","volume":"36","author":"Abarbanel","year":"1986","journal-title":"Neurology"},{"issue":"3 Pt 1","key":"10.1016\/j.ncl.2014.05.001_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1212\/WNL.44.3_Part_1.461","article-title":"Clinical and biochemical features of 10 adult patients with muscle phosphorylase kinase deficiency","volume":"44","author":"Wilkinson","year":"1994","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2014.05.001_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.410280410","article-title":"Adult phosphorylase b kinase deficiency","volume":"28","author":"Clemens","year":"1990","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF00662642","article-title":"Myopathic evolution of an exertional muscle pain syndrome with phosphorylase b kinase deficiency","volume":"81","author":"Carrier","year":"1990","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1054\/jocn.1999.0230","article-title":"Adult-onset exercise intolerance due to phosphorylase b kinase deficiency","volume":"8","author":"Bak","year":"2001","journal-title":"J\u00a0Clin Neurosci"},{"issue":"20","key":"10.1016\/j.ncl.2014.05.001_bib18","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/01.wnl.0000289190.66955.67","article-title":"Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?","volume":"70","author":"Orngreen","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajmg.a.30517","article-title":"Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene","volume":"133A","author":"Wuyts","year":"2005","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.ncl.2014.05.001_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nmd.2009.11.004","article-title":"Muscle phosphorylase b kinase deficiency revisited","volume":"20","author":"Echaniz-Laguna","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.ncl.2014.05.001_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/WNL.0b013e31824365f9","article-title":"Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?","volume":"78","author":"Preisler","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1006\/bbrc.1998.9211","article-title":"A\u00a0splice junction mutation in the alpha(M) gene of phosphorylase kinase in a patient with myopathy","volume":"249","author":"Bruno","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.ncl.2014.05.001_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.ejhg.5200996","article-title":"Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases","volume":"11","author":"Burwinkel","year":"2003","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10.1016\/j.ncl.2014.05.001_bib24","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1093\/hmg\/3.11.1983","article-title":"Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit","volume":"3","author":"Wehner","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1073\/pnas.77.1.62","article-title":"Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system","volume":"77","author":"Vora","year":"1980","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1212\/WNL.62.1.82","article-title":"No spontaneous second wind in muscle phosphofructokinase deficiency","volume":"62","author":"Haller","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2014.05.001_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199102073240603","article-title":"Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency","volume":"324","author":"Haller","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ncl.2014.05.001_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nmd.2011.10.022","article-title":"Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII)","volume":"22","author":"Musumeci","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"19","key":"10.1016\/j.ncl.2014.05.001_bib29","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1093\/hmg\/dds123","article-title":"Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing","volume":"21","author":"Timal","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.ncl.2014.05.001_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMc0901158","article-title":"Muscle glycogenosis due to phosphoglucomutase 1 deficiency","volume":"361","author":"Stojkovic","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10545-012-9525-7","article-title":"A\u00a0novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene","volume":"36","author":"Perez","year":"2013","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.ncl.2014.05.001_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1206605","article-title":"Multiple phenotypes in phosphoglucomutase 1 deficiency","volume":"370","author":"Tegtmeyer","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ncl.2014.05.001_bib33","doi-asserted-by":"crossref","first-page":"E1235","DOI":"10.1210\/jc.2013-1651","article-title":"Fat and carbohydrate metabolism during exercise in phosphoglucomutase type 1 deficiency","volume":"98","author":"Preisler","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nmd.2008.12.004","article-title":"Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations","volume":"19","author":"Spiegel","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archneurol.2008.584","article-title":"Muscle phosphoglycerate mutase deficiency revisited","volume":"66","author":"Naini","year":"2009","journal-title":"Arch Neurol"},{"issue":"17","key":"10.1016\/j.ncl.2014.05.001_bib36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1056\/NEJM199604253341705","article-title":"Brief report: inherited metabolic myopathy and hemolysis due to a mutation in aldolase A","volume":"334","author":"Kreuder","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ncl.2014.05.001_bib37","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2003-09-3160","article-title":"Hemolytic anemia and severe rhabdomyolysis caused by compound heterozygous mutations of the gene for erythrocyte\/muscle isozyme of aldolase, ALDOA(Arg303X\/Cys338Tyr)","volume":"103","author":"Yao","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ncl.2014.05.001_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.1095","article-title":"Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis","volume":"50","author":"Comi","year":"2001","journal-title":"Ann Neurol"},{"issue":"15","key":"10.1016\/j.ncl.2014.05.001_bib39","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa066691","article-title":"Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0","volume":"357","author":"Kollberg","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ncl.2014.05.001_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ymgme.2009.07.012","article-title":"Identification of a novel mutation in GYS1 (muscle-specific glycogen synthase) resulting in sudden cardiac death, that is diagnosable from skin fibroblasts","volume":"98","author":"Cameron","year":"2009","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.ncl.2014.05.001_bib41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nmd.2011.08.008","article-title":"Muscle glycogen storage disease 0 presenting recurrent syncope with weakness and myalgia","volume":"22","author":"Sukigara","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"13","key":"10.1016\/j.ncl.2014.05.001_bib42","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa0900661","article-title":"Glycogenin-1 deficiency and inactivated priming of glycogen synthesis","volume":"362","author":"Moslemi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2014.05.001_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/8904_2012_134","article-title":"Mutation analysis in glycogen storage disease type III patients in the Netherlands: novel genotype-phenotype relationships and five novel mutations in the AGL gene","volume":"7","author":"Sentner","year":"2013","journal-title":"JIMD Rep"},{"issue":"7","key":"10.1016\/j.ncl.2014.05.001_bib44","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen storage disease type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.ncl.2014.05.001_bib45","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/BF00443106","article-title":"Cardiac involvement in glycogen storage disease type III","volume":"148","author":"Moses","year":"1989","journal-title":"Eur J Pediatr"},{"issue":"8","key":"10.1016\/j.ncl.2014.05.001_bib46","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/hrt.34.8.862","article-title":"Gross cardiac involvement in glycogen storage disease type 3","volume":"34","author":"Miller","year":"1972","journal-title":"Br Heart J"},{"issue":"10","key":"10.1016\/j.ncl.2014.05.001_bib47","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archneur.1984.04050210025008","article-title":"Clinical varieties of neuromuscular disease in debrancher deficiency","volume":"41","author":"Cornelio","year":"1984","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2014.05.001_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1651-2227.1986.tb10201.x","article-title":"Neuromuscular involvement in glycogen storage disease type III","volume":"75","author":"Moses","year":"1986","journal-title":"Acta Paediatr Scand"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2013.02.008","article-title":"Exercise intolerance in glycogen storage disease type III: weakness or energy deficiency?","volume":"109","author":"Preisler","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"7","key":"10.1016\/j.ncl.2014.05.001_bib50","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/GIM.0b013e3181cd735b","article-title":"The electrodiagnostic characteristics of glycogen storage disease type III","volume":"12","author":"Hobson-Webb","year":"2010","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/jnnp.67.3.364","article-title":"Different clinical aspects of debrancher deficiency myopathy","volume":"67","author":"Kiechl","year":"1999","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2014.05.001_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/8904_2011_111","article-title":"Heart Failure due to severe hypertrophic cardiomyopathy reversed by low calorie, high protein dietary adjustments in a glycogen storage disease type IIIa patient","volume":"5","author":"Sentner","year":"2012","journal-title":"JIMD Rep"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2014.05.001_bib53","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1007\/s10545-009-1088-x","article-title":"Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet","volume":"32","author":"Dagli","year":"2009","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"10","key":"10.1016\/j.ncl.2014.05.001_bib54","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1016\/S0021-9258(18)53204-X","article-title":"Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast","volume":"268","author":"Thon","year":"1993","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib55","first-page":"75","article-title":"Neuromuscular forms of glycogen branching enzyme deficiency","volume":"26","author":"Bruno","year":"2007","journal-title":"Acta Myol"},{"key":"10.1016\/j.ncl.2014.05.001_bib56","series-title":"Gene reviews\u2122","article-title":"Glycogen storage disease type IV","author":"Magoulas","year":"2013"},{"issue":"4","key":"10.1016\/j.ncl.2014.05.001_bib57","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1172\/JCI118517","article-title":"Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene","volume":"97","author":"Bao","year":"1996","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib58","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ana.23598","article-title":"Adult polyglucosan body disease: natural history and key magnetic resonance imaging findings","volume":"72","author":"Mochel","year":"2012","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/5030","article-title":"Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter","volume":"21","author":"Nezu","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.ncl.2014.05.001_bib60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1750-1172-7-68","article-title":"Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management","volume":"7","author":"Magoulas","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.ncl.2014.05.001_bib61","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/324121","article-title":"Mutations in CGI-58, the gene encoding a new protein of the esterase\/lipase\/thioesterase subfamily, in Chanarin-Dorfman syndrome","volume":"69","author":"Lefevre","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.ncl.2014.05.001_bib63","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archneurol.2011.631","article-title":"Blocked muscle fat oxidation during exercise in neutral lipid storage disease","volume":"69","author":"Laforet","year":"2012","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2014.05.001_bib64","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bbrc.2008.03.010","article-title":"Clinical and genetic characterization of Chanarin-Dorfman syndrome","volume":"369","author":"Bruno","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.ncl.2014.05.001_bib65","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneurol.2011.2600","article-title":"A\u00a0novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy","volume":"69","author":"Ash","year":"2012","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2014.05.001_bib66","first-page":"1987","article-title":"The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene","volume":"258","author":"Reilich","year":"2011","journal-title":"J\u00a0Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2014.05.001_bib67","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2010.06.018","article-title":"Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges","volume":"20","author":"Laforet","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.ncl.2014.05.001_bib68","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00109-011-0725-7","article-title":"Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A","volume":"89","author":"Wang","year":"2011","journal-title":"J\u00a0Mol Med"},{"issue":"21","key":"10.1016\/j.ncl.2014.05.001_bib69","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.2169\/internalmedicine.50.5172","article-title":"A\u00a0case of late onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency manifesting as recurrent rhabdomyolysis and acute renal failure","volume":"50","author":"Izumi","year":"2011","journal-title":"Intern Med"},{"issue":"Pt 8","key":"10.1016\/j.ncl.2014.05.001_bib70","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awm135","article-title":"ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"130","author":"Olsen","year":"2007","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.ncl.2014.05.001_bib71","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1212\/WNL.44.11.2153","article-title":"Late-onset riboflavin-responsive myopathy with combined multiple acyl coenzyme A dehydrogenase and respiratory chain deficiency","volume":"44","author":"Antozzi","year":"1994","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1016\/j.ncl.2014.05.001_bib72","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awm054","article-title":"The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene","volume":"130","author":"Gempel","year":"2007","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ncl.2014.05.001_bib73","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10545-011-9434-1","article-title":"Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10)","volume":"35","author":"Horvath","year":"2012","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib74","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11910-010-0154-y","article-title":"Lipid storage myopathy","volume":"11","author":"Liang","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5\u20136","key":"10.1016\/j.ncl.2014.05.001_bib75","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects","volume":"25","author":"Bonnefont","year":"2004","journal-title":"Mol Aspects Med"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib76","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.20320","article-title":"Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations","volume":"57","author":"Orngreen","year":"2005","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2014.05.001_bib77","first-page":"1412","article-title":"Expanding mutation spectrum in CPT II gene: identification of four novel mutations","volume":"260","author":"Joshi","year":"2013","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/clpt.2010.55","article-title":"Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency","volume":"88","author":"Bonnefont","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ncl.2014.05.001_bib79","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nmd.2009.02.007","article-title":"Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency","volume":"19","author":"Laforet","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.ncl.2014.05.001_bib80","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/302261","article-title":"Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency","volume":"64","author":"Andresen","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.ncl.2014.05.001_bib81","first-page":"351","article-title":"State of the art in muscle lipid diseases","volume":"29","author":"Liang","year":"2010","journal-title":"Acta Myol"},{"issue":"18","key":"10.1016\/j.ncl.2014.05.001_bib82","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/hmg\/ddi303","article-title":"Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders","volume":"14","author":"Djouadi","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.ncl.2014.05.001_bib83","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tem.2011.02.006","article-title":"Dual function lipin proteins and glycerolipid metabolism","volume":"22","author":"Harris","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ncl.2014.05.001_bib84","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10545-012-9461-6","article-title":"Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia","volume":"35","author":"Michot","year":"2012","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"8","key":"10.1016\/j.ncl.2014.05.001_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrneurol.2013.126","article-title":"The clinical maze of mitochondrial neurology","volume":"9","author":"DiMauro","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"Pt 11","key":"10.1016\/j.ncl.2014.05.001_bib86","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/brain\/awp221","article-title":"Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy","volume":"132","author":"Horvath","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib87","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/hmg\/ddt393","article-title":"Elevated FGF21 secretion, PGC-1alpha and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle","volume":"23","author":"Crooks","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.ncl.2014.05.001_bib88","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","article-title":"FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study","volume":"10","author":"Suomalainen","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1\u20133","key":"10.1016\/j.ncl.2014.05.001_bib89","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10540-007-9036-1","article-title":"Disorders of nuclear-mitochondrial intergenomic communication","volume":"27","author":"Spinazzola","year":"2007","journal-title":"Biosci Rep"},{"issue":"1\u20133","key":"10.1016\/j.ncl.2014.05.001_bib90","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10540-007-9043-2","article-title":"Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches","volume":"27","author":"Lara","year":"2007","journal-title":"Biosci Rep"},{"issue":"7","key":"10.1016\/j.ncl.2014.05.001_bib91","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nmd.2010.03.017","article-title":"Mitochondrial DNA depletion syndromes\u2013many genes, common mechanisms","volume":"20","author":"Suomalainen","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib92","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2007.12.022","article-title":"CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures","volume":"82","author":"Mollet","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"Pt 1","key":"10.1016\/j.ncl.2014.05.001_bib93","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/brain\/awq273","article-title":"Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene","volume":"134","author":"Gerards","year":"2011","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cmet.2010.08.002","article-title":"Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I","volume":"12","author":"Nouws","year":"2010","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.ncl.2014.05.001_bib95","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ajhg.2007.12.012","article-title":"Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance","volume":"82","author":"Mochel","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2014.05.001_bib96","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.0954-6820.1969.tb07314.x","article-title":"Hereditary abnormal muscle metabolism with hyperkinetic circulation during exercise","volume":"185","author":"Linderholm","year":"1969","journal-title":"Acta Med Scand"},{"issue":"Pt 2","key":"10.1016\/j.ncl.2014.05.001_bib97","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/brain\/awg028","article-title":"The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients","volume":"126","author":"Taivassalo","year":"2003","journal-title":"Brain"},{"issue":"9\u201310","key":"10.1016\/j.ncl.2014.05.001_bib98","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.bbagrm.2011.11.009","article-title":"Mechanism of protein biosynthesis in mammalian mitochondria","volume":"1819","author":"Christian","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.ncl.2014.05.001_bib99","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/421530","article-title":"Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA)","volume":"74","author":"Bykhovskaya","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.ncl.2014.05.001_bib100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajhg.2010.06.001","article-title":"Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia\u2013MLASA syndrome","volume":"87","author":"Riley","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.ncl.2014.05.001_bib101","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/jmg.2011.089995","article-title":"Reversible infantile respiratory chain deficiency is a unique, genetically heterogenous mitochondrial disease","volume":"48","author":"Uusimaa","year":"2011","journal-title":"J\u00a0Med Genet"},{"issue":"2\u20133","key":"10.1016\/j.ncl.2014.05.001_bib102","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbabio.2004.09.007","article-title":"Implications of exercise training in mtDNA defects\u2013use it or lose it?","volume":"1659","author":"Taivassalo","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 11","key":"10.1016\/j.ncl.2014.05.001_bib103","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1093\/brain\/awn252","article-title":"Resistance training in patients with single, large-scale deletions of mitochondrial DNA","volume":"131","author":"Murphy","year":"2008","journal-title":"Brain"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861914000358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861914000358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T01:15:47Z","timestamp":1649639747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861914000358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":103,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0733861914000358"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2014.05.001","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic and Mitochondrial Myopathies","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}